Evaluation of the usefulness of protocol‐based pharmacist‐facilitated laboratory monitoring to ensure the safety of immune checkpoint inhibitors in patients with lung cancer

WHAT IS KNOWN AND OBJECTIVE: Immune checkpoint inhibitors can cause immune‐related adverse events (irAEs). Improved monitoring systems for irAEs, which include laboratory tests by a qualified multidisciplinary team, might prevent patients from irAE‐associated events. Kobe City Medical Center General...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:J Clin Pharm Ther
Hlavní autoři: Ikesue, Hiroaki, Kusuda, Kaori, Satsuma, Yukari, Nishiwaki, Fuki, Miura, Rieko, Masuda, Yoshio, Hirabatake, Masaki, Muroi, Nobuyuki, Fujimoto, Daichi, Morimoto, Takeshi, Tomii, Keisuke, Hashida, Tohru
Médium: Artigo
Jazyk:Inglês
Vydáno: John Wiley and Sons Inc. 2020
Témata:
Original Articles
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7687122/
https://ncbi.nlm.nih.gov/pubmed/32519774
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/jcpt.13207
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky